Johnson & Johnson
Change company Symbol lookup
Select an option...
JNJ Johnson & Johnson
LSEAW Landsea Homes Equity Warrant Exp 7th Jan 2026 *W EXP 01/07/2026
KEGS 1812 Brewing Company Inc
PHUN Phunware Inc
WFC Wells Fargo & Co
XRX Xerox Holdings Corp
BIDU Baidu Inc
CDRO Codere Online Luxembourg SA
AMZN Amazon.com Inc
LYFT Lyft Inc
Go

Health Care : Pharmaceuticals | Large Cap Blend
Company profile

Johnson & Johnson is a holding company that is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates through three segments: Consumer Health, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer Health segment includes a range of products that is focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopaedics, surgery, and vision fields. Its geographic area includes the United States, Europe, Western Hemisphere (excluding the United States), and Africa, Asia and Pacific.

Price
Delayed
$177.37
Day's Change
-1.37 (-0.77%)
Bid
--
Ask
--
B/A Size
--
Day's High
177.96
Day's Low
177.01
Volume
(Light)

Today's volume of 1,646,810 shares is on pace to be much lighter than JNJ's 10-day average volume of 6,233,846 shares.

1,646,810

JNJ's position in the Pharmaceuticals industry

Industry PeersJNJLLYMRKPBHRETA

Summary

Company ProfileJohnson & Johnson is a holding company that is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates through three...
Eli Lilly and Company is engaged in a drug manufacturing business. The Company discovers, develops, manufactures, and markets products in the human pharmaceutical products segment. Its diabetes...
Go to LLY summary
Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through...
Go to MRK summary
Prestige Consumer Healthcare Inc. is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers...
Go to PBH summary
Reata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is focused on identifying, developing, and commercializing therapies. The Company is also focused on providing...
Go to RETA summary
52-Week Change

VS. INDUSTRY
13.07%
48.65%
47.50%
9.98%
-57.51%
Market Cap

VS. INDUSTRY
$467.3B
$351.9B
$278.4B
$3.1B
$1.4B
Beta

VS. INDUSTRY
0.6
0.4
0.4
0.6
1.2
Dividend Yield

VS. INDUSTRY
2.53%
1.06%
2.66%
--
--
P/E (TTM, GAAP)

VS. INDUSTRY
24.88x
55.66x
18.19x
15.27x
--
Data as of

Fundamentals

Total Revenue (TTM)

VS. INDUSTRY
$96.0B
$29.2B
$59.0B
$1.1B
$3.1M
Profit Margin

VS. INDUSTRY
19.95%
20.63%
26.00%
18.83%
-9,901.05%
Earnings Growth
(5 year, GAAP)

VS. INDUSTRY
5.65%
18.88%
28.17%
25.44%
--
Revenue Growth (TTM)

VS. INDUSTRY
5.02%
5.34%
27.84%
8.39%
-77.09%
Data as of
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.